Saliva from a tick’s bite can transmit pathogens that cause serious illnesses, such as Lyme disease, and significant agricultural losses. Current insecticides have drawbacks, so scientists have been seeking new...
Scientists at the National Agriculture Research Organization-NARO have made a breakthrough in developing an anti-tick vaccine which is expected to give a long-lasting solution to the tick problem affecting farmers...
Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body’s defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according...
The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system. In a new paper published in Cell, researchers found that oral antibiotics, which can kill...
Virus experts from Cardiff University’s School of Medicine have uncovered, for the first time, how a virus known as Adenovirus type 26 (Ad26), which has been used effectively in a tamed form as a vaccine, can infect...
Giving children an additional dose of rotavirus vaccine when they are nine months old would provide only a modest improvement in the vaccine’s effectiveness in low-income countries concerned about waning...
A team led by the Walter Reed Army Institute of Research has gained new insights into the mechanism of vaccine-induced T cell immunity utilizing single-cell RNA sequencing and metabolic profiling techniques. Though...
A unique formulation of multiple amino acids inhibits the replication of Zika virus by up to 90 percent in human and non-human primate cells, according to a study led by Georgia State University. The study authors...
After more than fifty years of trying, a potential new chlamydia vaccine has at last reached phase 1 clinical trials. Not only was the vaccine found to be safe and well-tolerated when administered to humans, it was also...
A randomized clinical trial taking place in the Democratic Republic of the Congo has been terminated early due to the extraordinary success of two drugs being investigated to treat the Ebola virus. Four new treatments...